Click on image to view larger version.

Figure 3 Plot of the odds ratios (OR) with 95% confidence intervals of the 28-day primary end point for clopidogrel versus placebo based on duration of pre-treatment and glycoprotein (GP) IIb/IIIa antagonist use.